Local Support

We are a global leader in the field of rapid diagnostic tests designed to improve the quality of patient care. Specific product lines include tests for rapid and early diagnosis in the fields of cardiovascular, infectious diseases, women's health, drugs of abuse and oncology.

Viewpoints

Point-of-care diagnostics is a growing and dynamic industry helping to improve clinical and economic outcomes globally. Discover a variety of expert viewpoints on new innovations, insights, and impacts that are shaping the future of diagnostics around the world.

Products & Services

Cardiometabolic

Our products and services include tests to assist in the diagnosis and management of many cardiometabolic factors and conditions including cardiac markers, glucose and HbA1C, cholesterol levels, blood gases, and home monitoring for VAD and oral anticoagulation.

Toxicology Products & Services

Alere™ Toxicology offers drug testing products and services that are used in a multitude of settings such as hospitals, clinics, physician offices, criminal justice, workplace, rehabilitation, occupational health clinics, and home testing.

IQCP Support Resources

The Clinical Laboratory Improvement Amendments (CLIA) program recently introduced the Individualized Quality Control Plan (IQCP) as a new quality control option for nonwaived testing. We are pleased to provide you with materials to support your IQCPs.

Executive Team

The senior management team of Alere is comprised of global healthcare leaders with diverse and complementary backgrounds. The team meets regularly and focuses on the key strategic, financial, operational, and policy issues affecting the company.

Namal Nawana

Chief Executive Officer and President

Namal Nawana is Chief Executive Officer, President and a Member of the Board of Directors of Alere. ...
Namal’s career experience has fueled a passionate belief that strategic innovation can achieve better...
Namal currently serves on the Board of Directors of AdvaMedDx, the industry association that advocates...
Before joining Alere, Namal held various global leadership roles during his 15-year tenure at Johnson...
Namal was born in Sri Lanka and raised in Australia. He holds an Honors degree in Mechanical Engineering...

Namal Nawana is Chief Executive Officer, President and a Member of the Board of Directors of Alere. Since his appointment in 2014, Namal has re-oriented the company to focus on its strengths, as the global leader in rapid diagnostics behind the new vision of Knowing now matters.™ Through this strategic reset, Alere is positioned for improved financial performance, a strengthened balance sheet, a focused innovation pipeline and a return to organic growth.

Namal’s career experience has fueled a passionate belief that strategic innovation can achieve better access, quality and effectiveness of healthcare. In his current role, he is focused on unlocking the full potential of Alere’s assets and improving shareholder return by leveraging the company’s leadership in rapid diagnostics to develop solutions supporting each of these critical dimensions of healthcare.

Namal currently serves on the Board of Directors of AdvaMedDx, the industry association that advocates for the power of medical diagnostic tests to promote wellness, improve patient outcomes and advance public health globally; as well as the Board of Directors of Malaria No More, a global nonprofit with the mission to mobilize global resources required to achieve malaria eradication within the next 25 years.

Before joining Alere, Namal held various global leadership roles during his 15-year tenure at Johnson & Johnson. He most recently served as Worldwide President of DePuy Synthes Spine, a Johnson & Johnson company. Prior to that role, Namal held general management positions spanning the globe, including Area Vice President for Johnson & Johnson Medical in Australia and New Zealand and Chairman of the DePuy Asia Pacific Franchise Council. In these and other leadership roles, Namal drove continuous growth, innovation and profitability in a variety of specialties and technology fields. He also led diverse scientific and engineering functions as well as commercial operations during the 10-year period he spent living and working in Europe.

Namal was born in Sri Lanka and raised in Australia. He holds an Honors degree in Mechanical Engineering and a Masters of Medical Science degree from the University of Adelaide in Australia and an MBA from the Henley Business School in the United Kingdom.

John Bridgen, Ph.D.

Senior Vice President, Business Development

John Bridgen, Ph.D. has served as Senior Vice President, Business Development since July 2010, after...

John Bridgen, Ph.D. has served as Senior Vice President, Business Development since July 2010, after serving as our Vice President, Business Development from June 2006 to July 2010. He served as our Vice President, Strategy from September 2005 to June 2006. Dr. Bridgen joined our Company in September 2002, upon our acquisition of Wampole Laboratories, LLC. Dr. Bridgen served as President of Wampole from August 1984 until September 2005. Prior to joining Wampole, Dr. Bridgen had global sales and marketing responsibility for the hematology and immunology business units of Ortho Diagnostic Systems Inc., a Johnson & Johnson company.

Ellen Chiniara

Ellen Chiniara serves as Senior Vice President, General Counsel, Chief Ethics and Compliance Officer, and Secretary and is responsible for managing legal matters, government affairs and compliance for our Company. Ms. Chiniara joined us in October 2006 as General Counsel, Professional Diagnostics and Assistant Secretary and became our Vice President and General Counsel in May 2007, Secretary in May 2010, and Chief Ethics and Compliance Officer in June 2014. From 2002 to 2006, Ms. Chiniara was Associate General Counsel, Neurology of Serono, Inc., a biopharmaceutical company. Previously, she served as General Counsel to a healthcare venture capital fund and a healthcare management services organization, where she also was Chief Operating Officer of its clinical trial site management division. From 1994 to 1997, Ms. Chiniara was Assistant General Counsel at Value Health, a specialty managed healthcare company where she focused on disease management and healthcare IT. Prior to 1994, Ms. Chiniara was a partner with Hale and Dorr (now Wilmer Hale).

Daniella Cramp

Global President, Cardiometabolic

Daniella Cramp has served as Global President of our cardiometabolic business unit since January 2014...

Daniella Cramp has served as Global President of our cardiometabolic business unit since January 2014. In that role she focuses on cardiovascular and diabetes diagnostics and services across the entire continuum of care from the hospital to the home. From March through December 2013, Ms. Cramp was Global President of Chronic Care. Previously, she served as Vice President of our cardiovascular business unit from September 2007 through March 2013. Ms. Cramp joined Alere in June 2007 upon our acquisition of Biosite, where she had served as director of marketing from 2004 to 2007. Prior to that, Ms. Cramp was the director of Biosite’s physician office segment where she initiated Biosite’s entry into the outpatient setting with its diagnostic platform, Triage. Ms. Cramp also served as the product director for the launch of the Triage BNP Test, the world’s first blood test for heart failure diagnosis. Prior to joining Biosite, Ms. Cramp worked in the pharmaceutical industry for Astra Merck and later AstraZeneca from 1994 to 2000 in various sales and marketing roles supporting cardiovascular and gastrointestinal pharmaceutical products.

Mark Gladwell

Senior Vice President, Global Operations

Mark Gladwell has served as Senior Vice President, Global Operations since January 2015. From January...

Mark Gladwell has served as Senior Vice President, Global Operations since January 2015. From January 2014 through January 2015, he held the role of Vice President, Operations for North America, Europe, Middle East and Africa. From September 2011 through December 2013, Mr. Gladwell served as Vice President of Operations for North America and as President and General Manager of one of Alere’s key manufacturing facilities in North America. From 2007 to 2010 Mr. Gladwell was Vice President, Quality and Technical Service for Alere. From 2005 to 2007, he served as a director covering multiple functions in the start-up of Alere Technology Limited where he focused on the development and manufacture of the Alere home BNP product. Prior to 2005 Mr. Gladwell held a variety of operations, quality and project leadership positions in North America and Europe for Alere, Johnson & Johnson, Agfa Gavert and DuPont. Mr. Gladwell has more than 18 years of experience in manufacturing high-volume, high-technology in-vitro diagnostics and medical devices.

Kjersti Grimsrud

President, International, and President, Europe and Middle East

Kjersti Grimsrud was appointed President, International and President, Europe and Middle East (EME) ...

Kjersti Grimsrud was appointed President, International and President, Europe and Middle East (EME) for Alere in August 2014. Previously, as Alere’s President, EME, Ms. Grimsrud successfully reorganized the business and established partnerships that drove revenue growth. Ms. Grimsrud has more than 25 years’ experience in the medical diagnostics industry with extensive expertise in sales, marketing, R&D and manufacturing. From 1986 through 2011, she served in a variety of roles at Axis-Shield of Oslo, Norway, including Managing Director, Commercial Director, Marketing Director and Research Scientist. Ms. Grimsrud has built high performing sales organizations through direct and indirect sales channels in more than 80 countries.

Melissa Guerdan

Senior Vice President, Global Quality and Regulatory

Melissa Guerdan joined us as Senior Vice President, Global Quality in August 2012. In October 2013, ...

Melissa Guerdan joined us as Senior Vice President, Global Quality in August 2012. In October 2013, she assumed additional responsibility for the Regulatory function and became Vice President, Global Quality and Regulatory. Prior to Alere, Ms. Guerdan was the Vice President of Quality Operations for Covidien’s Pharmaceuticals business from March 2008 to August 2012. In this capacity she was responsible for leading quality and compliance across 11 global manufacturing facilities producing and distributing products ranging from urological imaging systems, contrast media/delivery systems, nuclear medicine products, and specialty generic pharmaceuticals. Prior to that, Ms. Guerdan served as Director of Quality for Baxter’s Renal and Medication Delivery businesses from 2004 to 2008. In addition to these key leadership roles, Ms. Guerdan also held various quality positions at Pfizer and Aventis Behring.

Robert Hargadon

Senior Vice President, Global Human Resources

Robert Hargadon joined us as Senior Vice President, Global Human Resources in October 2010. He has over...

Robert Hargadon joined us as Senior Vice President, Global Human Resources in October 2010. He has over 30 years of experience in human resources, leadership and organization development. Mr. Hargadon served as Vice President, Human Resources at drugstore.com, an online pharmacy, from November 2006 through October 2010. Prior to that, Mr. Hargadon was General Manager, Corporate Learning and Development at Microsoft from September 2005 to April 2006 and held various human resources leadership positions at Boston Scientific Corporation, a medical device manufacturer, from 1997 to 2005, including Vice President of International Human Resources and Vice President, Leadership Development from September 1997 to June 2005. Mr. Hargadon also served as Vice President, Learning and Development at Fidelity investments from 1993 to 1997. Mr. Hargadon also has 15 years of experience with the consulting firms Novations Group, Inc. and Harbridge House, which was acquired by PricewaterhouseCoopers LLP.

James Hinrichs

Executive Vice President and Chief Financial Officer

James (“Jim”) Hinrichs joined Alere in April 2015 as Executive Vice President and Chief Financial Officer...

James (“Jim”) Hinrichs joined Alere in April 2015 as Executive Vice President and Chief Financial Officer, with global responsibility for Finance, Accounting, Procurement, IT and Shared Services. Prior to his appointment as CFO of Alere, Jim Hinrichs was CFO at CareFusion Corp., a global medical technology corporation, since 2010. He held this position through the completion of Becton Dickinson’s acquisition of CareFusion in March 2015. Prior to this role, Hinrichs served as SVP of Global Customer Support and, before that, Corporate Controller of CareFusion. Previously, he was Executive Vice president and Controller of Cardinal Health, CFO of Cardinal Health’s Clinical and Medical Products segment and CFO of Cardinal Health's Healthcare Supply Chain Services segment.. He joined Cardinal Health in February 2004, following 12 years of finance and marketing roles at Merck & Co. and two years as the CFO of SangStat Medical Corporation.

Sanjay Malkani

Global President, Toxicology

Sanjay Malkani has served as Global President, Toxicology since February 2013. Previously, he led our...

Sanjay Malkani has served as Global President, Toxicology since February 2013. Previously, he led our Global Toxicology unit as Vice President and has been directly responsible for the unit’s US and European operations since January 2011. Mr. Malkani joined the Company as Vice President of the Toxicology Strategic Business Unit in February 2008, with responsibility for the Global Toxicology growth strategy and management of the US Toxicology operations. Previously at Roche Diagnostics, Mr. Malkani served as Vice President of Marketing for US Point-of-Care Diagnostics during 2006 to 2007, Vice President of Marketing for US Diabetes Care Hospital in 2005, and held successive sales and marketing roles in the US Diabetes Care business between 2001 and 2005. Prior to 2001, Mr. Malkani held various commercial positions at the Cambridge Group, Inc. and several start-up technology companies. Mr. Malkani completed his MBA at the Kellogg Graduate School of Management, and previously held several sales positions at the Dow Chemical Company, Inc., where he started his career in 1991.

Avi Pelossof

Global President, Infectious Disease

Avi Pelossof was appointed Global President of our Infectious Disease business unit in March 2013, after...

Avi Pelossof was appointed Global President of our Infectious Disease business unit in March 2013, after serving as Vice President of that business from February 2008 to February 2013. In August 2014, Mr. Pelosoff assumed additional responsibilities for Alere in Africa and Latin America. Mr. Pelossof joined Alere as Vice President, Blood-Borne Pathogens in January 2007 and served in that role until January 2008. Mr. Pelossof has more than 20 years of experience in diagnostics, global health and international finance, including senior roles at Chembio Diagnostic Systems, a manufacturer of diagnostic tests for infectious diseases, and Citigroup.

Renuka Uppaluri, Ph.D.

Senior Vice President, Research & Development

Renuka Uppaluri joined us as Senior Vice President, Research & Development in February...

Renuka Uppaluri joined us as Senior Vice President, Research & Development in February 2015. Prior to Alere, Ms. Uppaluri served as Vice President of Global R&D for a division of Covidien from 2009 through 2015. In this capacity, Ms. Uppaluri led over 350 employees located in seven countries. During her time in this position, her organization launched several new products across all of the franchises in the division and integrated five acquisitions. Prior to that, Ms. Uppaluri was the General Manager of Global Engineering for a division at GE Healthcare from 2007 to 2009. In addition to these key leadership roles, Ms. Uppaluri also held various R&D positions throughout her 10-year tenure at GE Healthcare.